Production of the main surface antigen of Toxoplasma gondii in tobacco leaves and analysis of its antigenicity and immunogenicity

Molecular Biotechnology

Volumn 30, Issue 1, 2005, Pages 41-49

  Clemente, Marina ^a,b   Curilovic, Roberto ^b   Sassone, Alina ^b   Zelada, Alicia ^b   Angel, Sergio O ^a   Mentaberry, Alejandro N ^b  

^a INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Plant transient expression; PVX amplicon; Toxoplasma gondii

Indexed keywords

BACTERIA; DISEASES; IMMUNOLOGY; PLANTS (BOTANY); TOBACCO; VIRUSES;

PLANT TRANSIENT EXPRESSION; PVX AMPLICON; SUBGENOMIC PROMOTERS; TOXOPLASMA GONDII;

ANTIGENS;

COAT PROTEIN; IMMUNOGLOBULIN G2A; MEMBRANE ANTIGEN; PLANT EXTRACT; SIGNAL PEPTIDE; SURFACE ANTIGEN 1; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG; VIRUS VECTOR;

AMPLICON; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPLAST; BLOOD SAMPLING; BODY BURDEN; BRAIN CYST; CONTROLLED STUDY; FEMALE; FUNCTIONAL GENOMICS; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; GENE FUSION; GENETIC STRAIN; HETEROZYGOTE; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; LETHALITY; MOTION; MOUSE; NONHUMAN; PLANT LEAF; PLANT TISSUE; PLANT VIRUS; POTATO VIRUS X; PROMOTER REGION; PROVOCATION TEST; REVIEW; RHIZOBIUM; SOLUBILITY; TOBACCO; TOXOPLASMA GONDII; VACCINATION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BRAIN; CYSTS; FEMALE; GENE EXPRESSION; IMMUNOGLOBULIN G; MICE; MICE, INBRED C3H; PLANT LEAVES; POTEXVIRUS; PROTOZOAN PROTEINS; RHIZOBIUM; TOBACCO; TOXOPLASMA; TOXOPLASMOSIS;

BACTERIA; DISEASES; GENES; PLANTS; TOBACCO; VIRUSES;

AGROBACTERIUM; NICOTIANA TABACUM; POTATO VIRUS X; TOXOPLASMA GONDII;

EID: 26244446912     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Mason, H. S., Lam, D. M., and Arntzen, C. J. (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA 89, 11745-11749.
2. Giddings, G., Allison, G., Brooks, D., and Carter, A. (2000) Transgenic plants as factories for biopharmaceuticals. Nat. Biotechnol. 18, 1151-1155.
3. Daniell, H., Streatfield, S. J., and Wycoff, K. (2001) Medical molecular farming: production of antibodies, biopharmaceutical and edible vaccines in plants. Trends Plant Sci. 6, 219-226.
4. Streatfield, S. J. and Howard, J. A. (2003) Plant-based vaccines. Int. J. Parasitol. 33, 479-493.
5. Arakawa, T., Yu, J., Chong, D. K., Hough, J., Engel, P. C., and Langridge, W. H. (1998) A plant-based cholera toxin B subunnit-insulin fusion protein protects against the development of autoimmune diabetes. Nat. Biothechnol. 16, 934-938.
6. Mason, H. S., Haq, T. A., Clements, J. D., and Arntzen, C. J. (1998) Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a systhetic LT-B gene. Vaccine 16, 1336-1343.
7. Richter, L. J., Thanavala, Y., Arntzen, C. J., and Mason, H. S. (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 18, 1167-1171.
8. Lauterslager, T. G. M., Florack, D. E. A., van der Wal, T. J., Molthoff, J. W., Langeveld, J. P. M., Bosch, D., et al. (2001) Oral immunization of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine 19, 2749-2755.
9. Huang, Y., Liang, W., Pan, A., Zhou, Z., Huang, C., Chen, J., et al. (2003) Production of FaeG, the mejor subunit of K88 fimbriae, in transgenic tobacco plants and its immunogenicity in mice. Infect. Immun. 71, 5436-5439.
10. Peréz-Filgueira, D. M., Zamorano, P. I., Domínguez, M. G., Taboga, O., Del Mf - dico Zajac, M. P., Puntel, M., et al. (2003) Bovine herpes virus gD protein produced in plants using a recombinnant tobacco mosaic virus (TMV) vector possesses authentic antigenicity. Vaccine 21, 4201-4209.
11. Fischer, R., Vaquero-Martin, C., Sack, M., Drossard, J., Emans, N., and Commandeur, U. (1999) Towards molecular farming in the future: transient protein expression in plants. Biotechnol. Appl. Biochem. 30, 113-116.
12. Sala, F., Rigano, M. M., Barbante, A., Basso, B., Walmsley, A. M., and Castiglione, S. (2003) Vaccine antigen production in transgenic plants: strategies, gene constructs and perspective. Vaccine 21, 803-808.
13. Kapila, J., De Rycke, R., van Montagu, M., and Angenon, G. (1997) An Agrobacterium-mediated transient gene expression system in intact leaves. Plant Sci. 122, 101-108.
14. Tenter, A. M., Heckeroth, A. R., and Weiss, L. M. (2000) Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30, 1217-1258.
15. Dubey, J. P. (1990) Status of toxoplasmosis in sheep and goats in the United States. J. Am. Vet. Med. Assoc. 196, 259-262.
16. Duncanson, P., Terry, R. S., Smith, J. E., and Hide, G. (2001) High levels of congenital transmission of Toxoplasma gondii in a commercial sheep flock. Int. J. Parasitol. 31, 1699-1703.
17. Frenkel, J. K. and Escajadillo, A. (1987) Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis. Am. J. Trop. Med. Hyg. 36, 517-522.
18. Bout, D. T., Mévélec, M. N. Velge-Roussel, F., Dimier-Poisson, I., and Lebrun, M. (2002) Prospects for a human Toxoplasma vaccine. Curr. Drug. Targets Immune Endocr. Metabol. Disord. 2, 227-234.
19. Bhopale, G. M. (2003) Development of a vaccine for toxoplasmosis: current status. Microb. Infect. 5, 457-462.
20. Nagel, S. D. and Boothroyd, J. C. (1989) The mayor surface antigen, P30, of Toxoplasma gondii anchored by a glycolipid. J. Biol. Chem. 264, 5569-5574.
21. Skryabin, K. G., Kraev, A. S., Morosov, S. Y., Rosanov, M. N., Chernov, B. K., Lukasheva, L. I., et al. (1988) The nucleotide sequence of potato virus X RNA. Nucleic Acids Res. 16, 10929-10930.
22. Chapman, S., Hills, G., Watts, J., and Baulcombe, D. (1992) Virus X as a vector for gene expression in plants. Plant J. 2, 549-557.
23. Santa Cruz, S., Chapman, S., Roberts, A. G., Roberts, I. R., Prior, D. A. M., and Oparka, K. J. (1996) Assembly and movement of a plant virus carrying a green fluorescent protein overcoat. Proc. Natl. Acad. Sci. USA 93, 6286-6290.
24. Franconi, R., Di Bonito, P., Dibello, F., Accardi, L., Muller, A., Cirilli, A., et al. (2002) Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection. Cancer Res. 62, 3654-3658.
25. Orman, B. E., Celnik, R. M., Mandel, M. A., Torres, T. N., and Mentaberry, A. N. (1991) Complete nucleotide sequence of a South American isolate of potato virus X. Virus Res. 16, 293-305.
26. Nigro, M., Gutierrez, A., Hoffer, A. M., Clemente, M., Kanfer, F., Carral, L., et al. (2003) Evaluation of Toxoplasma gondii recombinant proteins for the diagnosis of recently acquired toxoplasmosis by an immunoglobulin G analysis. Diagn. Microbiol. Infect. Dis. 47, 609-613.
27. Mallory, A. C., Parks, G., Endres, M. W., Baulcombe, D., Bowman, L. H., Pruss, G. J., and Vance, V. B. (2002) The amplicon-plus system for high-level expression of transgenes in plants. Nat. Biothecnol. 20, 622-625.
28. Brigneti, G., Voinnet, O., Li, W. X., Ji, L., Ding, S. W., and Baulcombe, D. (1998) Viral pathogenicity determinant are suppressors of transgene silencing in Nicotiana benthamiana. EMBO J. 17, 6739-6746.
29. Harning, D., Spenter, J., Metsis, A., Vuust, J., and Petersen, E. (1996) Recombinant Toxoplasma gondii surface Antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin. Diagn. Lab. Immunol. 3, 355-357.
30. Chen, X. G., Gong, Y. H. U., Lun, Z. R., and Fung, M. C. (2001) High- level expression and purification of immunogenic recombinant SAG1 (p30) of Toxoplasma gondii in Escherichia coli. Protein Expr. Purif. 23, 33-37.
31. Letourner, O., Gervasi, G., Gaia, S., Pages, J., Watelet, B., and Jolivet, M. (2001) Characterization of Toxoplasma gondii surface, antigen 1 (SAG1) secreted from Pichia pastoris: evidence of hyper O-glycosylation. Biotechnol. Appl. Biochem. 33, 35-45.
32. Marti, M., Li, Y., Kohler, P., and Hehl, A. B. (2002) Conformationally correct expression of membrane-anchored Toxoplasma gondii SAG1 in the primitive protozoan Giardia duodenalis. Infect. Immunol. 70, 1014-1016.
33. Kim, K., Bulow, R., Kampmeier, J., and Boothroyd, J. C. (1994) Conformationally appropriate expression of the Toxoplasma antigen SAG1 (p30) in CHO cells. Infect. Immunol. 62, 203-209.
34. Meek, B., Diepersloot, R. J., Van Gool, T., Speijer, D., and Peek, R. (2003) IgM recognition of recombinant Toxoplasma gondii antigens by sera of acutely or latently infected humans. Diagn. Microbiol. Infect. Dis. 45, 45-52.
35. Biemans, R., Gregoire, D., Haumont, M., Bosseloir, A., Garcia, L., Jacquet, L., et al. (1998) The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation. J. Biotechnol. 66, 137-146.
36. Vaquero, C., Sack, M., Chandler, J., Drossard, J., Schuster, F., Moneck, M., et al. (1999) A carcinoembryonic antigen-specific antibody produced in tobacco. Proc. Natl. Acad. Sci. USA 96, 11128-11133.
37. Desolme, B., Mévélec, M. N., Buzoni-Gatel, D., and Bout, D. (2000) Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii Gra4 gene. Vaccine 18, 2512-2521.
38. Vercammen, M., Scorza, T., Huygen, K., De Braekeleer, J., Diet, R., Jacobs, D., et al. (2000) DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect. Immunol. 68, 38-45.
39. Martin, V., Supanitsky, A., Echeverria, P. C., Litwin, S., Tanos, T., de Roodt, A. R., et al. 2004. Recombinant Gra4 or Rop2 combined with alum or gra4 DNAa provides partial protection in chronic murine models of toxoplamosis. Clin. Diagn. Lab. Immunol. 11, 704-710.